moxifloxacin has been researched along with raltegravir potassium in 1 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (raltegravir potassium) | Trials (raltegravir potassium) | Recent Studies (post-2010) (raltegravir potassium) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 1,238 | 243 | 879 |
| Protein | Taxonomy | moxifloxacin (IC50) | raltegravir potassium (IC50) |
|---|---|---|---|
| Translocator protein | Rattus norvegicus (Norway rat) | 0.13 | |
| Integrase | Human immunodeficiency virus 1 | 0.0494 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bloomfield, DM; Breidinger, SA; Gottesdiener, KM; Iwamoto, M; Kost, JT; Marbury, TC; Mistry, GC; Stone, JA; Wagner, JA; Wenning, LA | 1 |
1 trial(s) available for moxifloxacin and raltegravir potassium
| Article | Year |
|---|---|
Raltegravir thorough QT/QTc study: a single supratherapeutic dose of raltegravir does not prolong the QTcF interval.
Topics: Adult; Anti-Infective Agents; Aza Compounds; Cross-Over Studies; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; HIV Integrase Inhibitors; Humans; Male; Middle Aged; Moxifloxacin; Pyrrolidinones; Quinolines; Raltegravir Potassium; Time Factors | 2008 |